Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



3M Adds New Products to Cavilon Brand Portfolio

3M Adds New Products to Cavilon Brand Portfolio

New 3M Cavilon Bathing & Cleansing Wipes and 3M Cavilon 3-in-1 Total Care Cloths Deliver Effective, Efficient Care

ST. PAUL, Minn.--(BUSINESS WIRE)-- 3M Critical & Chronic Care Solutions Division today announced the release of two new products, 3M™ Cavilon™ Bathing & Cleansing Wipes and 3M™ Cavilon™ 3-in-1 Total Care Cloths. The new offerings from 3M help clinicians to address the needs for efficacy and efficiency across care settings, and join the trusted line of Cavilon solutions used in incontinence care applications.

A concern for both patients and caregivers, incontinence can lead to the development of Incontinence-Associated Dermatitis (IAD), which is a well-known risk factor in the development of pressure ulcers.1 IAD has been reported to occur in 42 percent of incontinent hospitalized adults and up to 95 percent of incontinent patients in the intensive care unit.1,2 In addition, approximately 50 percent of nursing home residents live with incontinence on a daily basis.3

The new Cavilon products help clinicians adhere to IAD prevention protocols and simplify care regimens for efficiency. According to recent clinical consensus4 use of a soft, disposable cloth is a preferred approach for incontinence cleansing. In a U.S. comparison study, use of a no-rinse cleanser saved caregivers valuable time: an average of 9 minutes per episode5.

Cleansing, Moisturizing, Protecting

Both new Cavilon products combine gentle pH-balanced cleansing and emollient-based moisturizing ingredients, which help to maintain the skin’s natural barrier. Cavilon 3-in-1 Total Care Cloths also provide protection from moisture and irritants through the use of dimethicone, an ingredient well-documented as an effective protective barrier. New 3M Bathing & Cleansing Wipes, which are useful for bathing as well as incontinence care, are compatible with 3M’s protection barrier products, 3M™ Cavilon™ No Sting Barrier Film and 3M™ Cavilon™ Durable Barrier Cream. Each product is available in re-sealable 8- and 24-packs.

“Our new products are consistent with the high level of care expected from the Cavilon brand while addressing our customers’ need for efficient and convenient solutions,” said Leslie McDonnell, Vice President Global Marketing, 3M Chronic & Critical Care Solutions Division. “With these additions to our brand portfolio, we continue to expand our full suite of products for best practice care and improved patient outcomes.”

3M invites professional and non-professional caregivers and patients to visit for training, information and support. In addition, a dedicated toll-free helpline, 1-800-228-3957 has been established. For more information on 3M Critical & Chronic Care Solutions, visit

About 3M Health Care

3M Health Care offers solutions in the medical, oral care, drug delivery, food safety and health information markets. We have an unparalleled ability to connect people, insights, science and technology to think beyond today, solve problems, and make better health possible. Our culture of collaboration empowers us to discover and deliver practical, proven solutions that enable our customers to protect and improve the health of people around the world. Learn more at

1Incontinence Associated Dermatitis (IAD): Best Practice for Clinicians. Wound, Ostomy and Continence Nurses Society, 2011.

2Peterson KJ, Bliss DZ, Nelson C, Savik K. Practices of nurses and nursing assistants in preventing incontinence associated dermatitis in acutely/critically ill patients. Amer J of Crit Care. (Abstract) 2006; 15(3): 325.

3Bliss, D. Savik, K. & Peterson, K. Continence-evidence-based treatment and management: Incontinence-Dermatitis in Hospitalized Patients Prevalence. Evidence-Based Nursing Care and Nurse Education Program. Journal of Wound, Ostomy and Continence Nursing. 2009; 36(3S): S56.

4Doughty D, et al. Incontinence – Associated Dermatitis: Consensus Statements, Evidence – Based Guidelines for Prevention and Treatment, and Current Challenges. Journal of Wound, Ostomy and Continence Nursing. 2012; 39(3): 303-315.

5Lewis-Byers K, Thayer D, Kahl A. An evaluation of two incontinence skin care protocols in a long-term care setting. Ostomy Wound Management. 2005; 48(12): 44-51.

Mary Kokkinen, 651-733-8806
Heather Sheriff, 612-573-3105

KEYWORDS:   United States  North America  Minnesota


Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2493176, ~/Articles/ArticleHandler.aspx, 10/6/2015 4:27:10 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...